It is slightly unfortunate, Sir David, that the shadow Minister, Justin Madders, asked a lot of questions, because he took up a lot of time. Nevertheless, I will attempt to answer as many colleagues’ questions as possible.
Before setting out details of the plan for vaccination, I thank Tonia Antoniazzi for the incredible passion with which she spoke. I apologise that I was not in the room for her speech—I was in the main Chamber, as she will know—but it has always been our strategy to suppress the coronavirus until a vaccine can make us all safe, because we know ultimately that vaccines are our way out of this terrible pandemic.
This afternoon we launched our complete vaccine deployment plan, the culmination of months of preparation and hard work by the NHS, the armed forces—Ian Paisley mentioned the armed forces, and they are embedded in the deployment programme—and, of course, local and regional government at every level. The sooner we can reduce mortality from this pernicious disease and bring an end to that human suffering, the better.
It is worth reminding ourselves of just what that suffering looks like. Sadly, yesterday, 563 deaths were reported. The average number of deaths per day over the past week has been 909, and behind every statistic is a person—a father, a mother, a sister, a daughter, a grandfather or a grandmother—with family and friends. We must never lose sight of that.
In the light of the petition that we are discussing and, of course, the time, I will reflect on the basic principles that sit behind our prioritisation and our strategy. Yes, we want to minimise disruption for pupils, parents and teachers; yes, we want to stop the NHS being overwhelmed, and yes, we want to protect UK jobs and businesses as much as we possibly can, but fundamentally it is about saving lives, and operationally it is about saving as many lives as possible, as quickly as possible.
I defy anyone to provide more powerful grounds for action in order to achieve that. We are following the science and we are vaccinating, according to the prioritisation by the Joint Committee on Vaccination and Immunisation, which recommended rapid immunisation of our most vulnerable groups. It is worth reminding colleagues, as my hon. Friend Steve Brine did, about the first four categories, for whom we absolutely are focused on making sure they have the opportunity of a first dose to protect them by mid-February across all four nations.
I know Stephen Doughty and others are concerned about supplies, and he has contacted me about that. I can reassure him that, having spoken to my counterparts in the devolved Administrations that, while the supply lines have been lumpy—in any manufacturing process, especially one so complex as a novel vaccine that is a biological compound, it is always difficult at the outset, but they very quickly stabilise—we have clear line of sight of deliveries all the way through until the end of February, hence we are able to make the pledge that we will be able to deploy.